As drugmakers in the US steel for price negotiations ushered in by President Joe Biden’s Inflation Reduction Act, their experience in China, where such talks started almost a decade ago, could offer some insight into just how low costs may go. Beijing back in 2016 started to negotiate prices for…
China Drug-Price Negotiations Offers Glimpse Into Future for Companies in US bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
Key Takeaways: Junshi Biosciences reported dismal results in the first quarter, with operating income plunging nearly 60% and its net loss expanding by 37% Hopes of a big revenue boost from an oral Covid drug have been dashed, and the company may not recoup its investment in the short term By Molly Wen
SHANGHAI, China, May 07, 2023 Shanghai Junshi Biosciences Co., Ltd announced a collaboration with Dr. Reddy’s Laboratories Limited to develop and commercialize toripalimab, the anti-PD-1. | May 7, 2023
SHANGHAI, China, April 27, 2023 Shanghai Junshi Biosciences Co., Ltd , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of. | April 27, 2023